BPAX Insider Trading Activity and SEC Form 4 Filings
BPAX insider trading summary
No open-market insider purchases or sales of Biosante Pharmaceuticals Inc (BPAX) have been reported on SEC Form 4 in the past 12 months.
Latest BPAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 14, 2011 | Edward C Rosenow III | Director | Buy | $7K (3,000 @ $2.37) |
| Aug 15, 2011 | Louis W Sullivan | Director | Buy | $27K (10,000 @ $2.67) |
| Aug 12, 2011 | Ross J Mangano | Director | Buy | $60K (25,000 @ $2.40) |
| Aug 8, 2011 | Philip B Donenberg | Sr. VP of Finance, CFO & Secy | Buy | $2K (1,000 @ $2.23) |
| Aug 5, 2011 | Philip B Donenberg | Sr. VP of Finance, CFO & Secy | Buy | $2K (1,000 @ $2.19) |
| Aug 5, 2011 | Ross J Mangano | Director | Buy | $177K (80,000 @ $2.21) |
| Jan 21, 2011 | Philip B Donenberg | Sr. VP of Finance, CFO & Sec'y | Buy | $2K (1,000 @ $1.88) |
| Jan 19, 2011 | Philip B Donenberg | Sr. VP of Finance, CFO & Sec'y | Buy | $2K (1,000 @ $1.88) |
| Jan 18, 2011 | Stephen M Simes | Vice Chairman, President & CEO | Buy | $9K (5,000 @ $1.77) |
| Jan 13, 2011 | Louis W Sullivan | Director | Buy | $17K (10,000 @ $1.72) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.